Posts in category Insights

Oracle Corporation (ORCL): Here’s Why You Should Stick with the Bulls

Rosenblatt’s Marshall Senk anticipates the cloud model transition will prove to be a “multi year cycle” for this software giant.

Analyst Looks for NVIDIA Corporation (NVDA) Long-Term Product Portfolio to Take Center Stage on Analyst Day

RBC Capital’s Mitch Steves expects a double show from NVDA on Analyst Day- between products and financials.

Is It Worth Buying on Facebook Inc (FB) PR Scandal and Rocky Apple Inc. (AAPL) HomePod Speaker Sales?

Bulls shine light on two of the Street’s leading giants of the tech sector- amid FB’s alleged data breach and AAPL’s less-than-stellar HomePod sales.

Top Analyst Bullish on Adaptimmune Therapeutics PLC – ADR (ADAP) “Major” Share Drivers Set to Hit This Year

Cowen’s Eric Schmidt gives a vote of confidence to ADAP on back of yesterday’s fourth quarter financial and pipeline update., Inc. (AMZN) and Facebook Inc (FB) Could Emerge as the Dominant Forces in the TV Sports Rights Universe

GBH Insights’ Daniel Ives makes a case for AMZN and FB as two standout prospective players in sports programming.

Dicks Sporting Goods Inc (DKS): More Headwinds Ahead

RBC Capital’s Scot Ciccarelli delivers a cautious perspective on DKS shares following a mixed bag of a fourth quarter performance.

Where Will, Inc. (AMZN) Pick Its Next Headquarters? Wells Fargo Shares Two Cents

Wells Fargo’s Ken Sena believes Boston has the best odds for Amazon’s HQ2; here’s why:

TherapeuticsMD Inc (TXMD): Mega Metamorphosis Ahead? This Analyst Says Yes

Oppenheimer’s Jay Olson is liking the setup of TXMD shares more and more amid major commercial potential.

Analyst Cuts Price Target on Synergy Pharmaceuticals Inc (SGYP); All Chips Are Riding on Trulance Uptake

Though Cantor’s William Tanner keeps SGYP’s capital needs and prospective dilution in mind, he is confident on Trulance’s uptake in the market.

Synergy Pharmaceuticals Inc (SGYP): Trulance Picking Up Steam

H.C. Wainwright’s Ram Selvaraju is pleased to see Synergy’s momentum following a robust fourth quarter print and debt restructuring strides forward.